1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016-2020 Italy HIV/AIDS Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot

2016-2020 Italy HIV/AIDS Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot

  • March 2016
  • -
  • Venture Planning Group
  • -
  • 60 pages

Summary

Table of Contents

This DataPack presents Italian test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:

    - Hospitals
    - Commercial/Private Labs
    - Blood Banks

The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and Siemens.

List of Tables


Table 1.  Major Companies Developing or Marketing AIDS Tests
Table 2.  Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3.  Italy: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4.  Italy: Western Blot Tests Volume and Sales Forecast by Market Segment
Table 5.  Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6.  Italy: AIDS Diagnostics Market by Major Supplier
Table 7.  Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Contains 60 pages and 7 tables

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

2017 Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.